trevor bachmeyer retatrutide dosage Retatrutide, an investigational triple hormone receptor agonist that shows promise for weight loss in ongoing phase-3 clinical trials, is being sold openly across the internet and prescribed by licensed physicians online and Retatrutide Needs Carbohydrates to Work

Retatrutide is not approved by the MHRA or EMA

[DOI] [PubMed] [Google Scholar] 184.Luo J., Mills K., le Cessie S., Noordam R., van Heemst D

Other reported effects included: Transient fatigue Reduced appetite (therapeutically desirable in the context of weight loss) Mild injection-site reactions Altered skin sensations or cutaneous hyperesthesia (reported in ~7% of participants, mild and non-serious) Serious adverse events were rare and occurred at similar rates in the retatrutide and placebo groups (approximately 4%)

The GLP-1 prescription itself is straightforward (start low, titrate slowly, monitor for nausea/vomiting)

doi: 10.1007/s13679-019-00335-3

The brain: quieting "food noise." GLP-1 receptors in the hypothalamus and reward centers reduce appetite and the intrusive thoughts about food that many patients with obesity describe